DI PINO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 6.320
EU - Europa 3.979
AS - Asia 3.508
SA - Sud America 734
AF - Africa 650
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.200
Nazione #
US - Stati Uniti d'America 6.137
SG - Singapore 1.697
IT - Italia 1.370
RU - Federazione Russa 1.339
CN - Cina 767
BR - Brasile 617
IE - Irlanda 398
VN - Vietnam 360
CI - Costa d'Avorio 349
IN - India 210
FR - Francia 168
KR - Corea 131
CA - Canada 123
DE - Germania 113
GB - Regno Unito 113
SN - Senegal 105
UA - Ucraina 105
SE - Svezia 101
NG - Nigeria 93
TR - Turchia 53
HK - Hong Kong 48
NL - Olanda 48
FI - Finlandia 47
PL - Polonia 44
AR - Argentina 43
BD - Bangladesh 36
JP - Giappone 36
MX - Messico 35
ZA - Sudafrica 27
IQ - Iraq 25
ES - Italia 21
UZ - Uzbekistan 21
AT - Austria 20
BJ - Benin 20
PK - Pakistan 19
EC - Ecuador 18
MA - Marocco 17
KE - Kenya 14
LT - Lituania 14
LB - Libano 12
VE - Venezuela 12
CH - Svizzera 11
CO - Colombia 11
GR - Grecia 11
CL - Cile 10
ID - Indonesia 10
IR - Iran 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
AU - Australia 7
PA - Panama 7
SA - Arabia Saudita 7
BG - Bulgaria 6
NP - Nepal 6
TN - Tunisia 6
BO - Bolivia 5
ET - Etiopia 5
HR - Croazia 5
IL - Israele 5
RO - Romania 5
UY - Uruguay 5
AL - Albania 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
OM - Oman 4
PH - Filippine 4
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
PE - Perù 3
RS - Serbia 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
GE - Georgia 2
IS - Islanda 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
MY - Malesia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
DM - Dominica 1
EE - Estonia 1
Totale 15.183
Città #
Dallas 1.205
Singapore 1.078
Santa Clara 837
Chandler 611
Moscow 577
Dublin 395
San Jose 381
Ashburn 361
Abidjan 349
Chicago 293
Catania 265
Hefei 187
Beijing 170
Boardman 166
Los Angeles 163
Kochi 153
Civitanova Marche 146
Seoul 131
Jacksonville 127
Lauterbourg 125
Ho Chi Minh City 107
Cambridge 106
Council Bluffs 106
Dakar 105
Rome 103
Lawrence 102
Andover 101
Wilmington 72
Houston 71
Hanoi 70
New York 69
Dong Ket 67
Nanjing 58
Des Moines 57
São Paulo 55
Padova 54
Toronto 51
Buffalo 47
Milan 44
Abuja 43
Hong Kong 42
The Dalles 39
Palermo 38
Orem 37
Warsaw 36
Montreal 35
Lagos 34
Tokyo 34
Boydton 32
Bremen 30
Denver 30
Columbus 27
Stockholm 27
Lappeenranta 26
Amsterdam 24
Chennai 24
Munich 24
Belo Horizonte 23
Brooklyn 21
San Francisco 21
Cotonou 20
Johannesburg 20
Ottawa 19
London 18
Rosolini 18
Saint Petersburg 18
Carrara 17
Frankfurt am Main 17
Hebei 17
Rio de Janeiro 17
Seattle 17
Da Nang 16
Poplar 16
Port Harcourt 16
Atlanta 15
Istanbul 15
Manchester 15
Shenyang 14
Boston 13
Brasília 13
Jiaxing 13
Messina 13
Ankara 12
Helsinki 12
San Mateo 12
Tashkent 12
Washington 12
Nairobi 11
Naples 11
Nanchang 10
Shanghai 10
Bari 9
Charlotte 9
Enna 9
Mumbai 9
Phoenix 9
San Valentino Torio 9
Turku 9
Baghdad 8
Città Sant'Angelo 8
Totale 10.350
Nome #
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 385
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 261
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 220
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 194
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 181
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 174
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 172
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 164
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 164
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 161
A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study protocol 160
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 158
Antibiotic use and associated factors in a large sample of hospitalised older people 158
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 151
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 150
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 150
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 148
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 146
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 146
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 146
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 145
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 144
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 143
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 141
Clinical and molecular biomarkers for diagnosis and staging of nafld 141
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 141
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 140
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 139
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 139
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 138
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 137
Heart failure and chronic kidney disease in a registry of internal medicine wards 137
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 137
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 136
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 136
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 135
Smoking and diabetes: Dangerous liaisons and confusing relationships 133
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 132
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 131
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 131
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 130
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 129
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 129
Ultrasound in diagnosis of superior mesenteric artery syndrome 128
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 128
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 128
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 126
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 125
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 125
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 123
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 121
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 121
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 120
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 120
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 119
LONG NON-CODING RNA ASSOCIATI AL DIABETE MELLITO. FOCUS SULLE COMPLICANZE MICRO E MACROVASCOLARI 117
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 115
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 115
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 115
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 115
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 113
Correction: Smoking and diabetes: dangerous liaisons and confusing relationships 113
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 113
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 110
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 109
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 109
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 109
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 104
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 103
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 103
Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects 103
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications 102
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 102
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 102
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 101
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 100
Ruolo dei linfociti FoxP3 nella infezione cronica da virus C. Risultati preliminari di un protocollo di studio clinico [Lymphocytes Fox P3 and chronic C hepatitis: preliminary results] 100
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 100
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 98
L'emoglobina Glicosilata potrebbe identificare soggetti con normale tolleranza al glucosio ma con alterazione dei markers precoci di danno cardiovascolare. 97
Prediabete: Criteri diagnostici e rischio cardiovascolare 95
Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes 94
Role of HbA1c in identify subjects with prediabetes and preclinical cardiovascular risk. 94
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience 93
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 92
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 92
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 91
Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c 90
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People. 90
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 90
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 89
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity. 89
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 88
Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. 86
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 86
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 86
What changed in the Italian internal medicine and geriatric wards during the lockdown 86
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 85
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 85
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 84
Totale 12.670
Categoria #
all - tutte 49.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 0 0 0 0 0 57 88
2021/2022851 55 113 7 27 152 55 113 41 32 7 41 208
2022/20231.634 116 115 42 193 135 252 7 312 329 16 70 47
2023/2024917 37 169 48 28 50 189 27 112 16 29 125 87
2024/20253.599 67 484 197 310 679 456 178 114 171 297 431 215
2025/20267.441 426 409 1.444 603 1.116 1.550 841 148 412 482 10 0
Totale 15.494